Registration Opening Autumn 2021

Call for Abstract

Countdown:
Days

Abstract Submission Deadline Extended! Submit by December 3rd, 2021.

Abstracts should only be submitted online through the abstract scorecard. Abstracts sent via email will not be accepted.

There is still time to submit your abstract. The WFH 2022 Program Committee is pleased to announce that the abstract submission deadline has been extended until December 3rd, 2021, 11:59 PM ET. The notification on abstract acceptance will be made on the week of January 10th,2022, with the final programme presented at the end of January 2022.

There will be as many as 50 oral presentations of 12 minutes and 36 oral presentations of 3 minutes to be allocated, as well as electronic posters with audio and video pre-recordings and 100 complimentary printed posters. Detailed Guidelines will be made available in January.

This is a unique opportunity to present your research to the bleeding disorders community.

The WFH 2022 Program Committees invite abstracts focusing on medical and multidisciplinary approaches to bleeding disorders. The purpose of this abstract submission is to provide an outline for presentation to be given at the WFH 2022 World Congress, which will be a hybrid event with the in-person taking place in Montreal, Canada, from May 8 to 11, 2022.

The late-breaking abstract submission period is from February 2 to March 2, 2022. Late-breaking abstracts should describe the latest advances that will change our daily clinical practice and should highlight novel and practice-changing studies. The selection process will favour abstracts with ground-breaking and unique data that would not otherwise have been presented at the Congress. In every case, the results should not be fully available by the regular abstract submission deadline.

To submit your abstract

Step 1: Create your profile and login here.

Step 2: Complete all the tasks to submit your abstract. Once completed, be sure to click submit.

Editing a submission

You may edit your abstract after submitting up to the submission deadline of December 3, 2021.
To edit your abstract, login to the submission site with your email and password, to access your submission(s).

KEY DATES
Abstract deadline December 3, 2021, 11:59 p.m. ET
Notification to authors January 10 to 14, 2022
Abstract presenter registration deadline February 7, 2022
Late-breaking Abstract Opens: February 2, 2022. Deadline: March 2, 2022, at 11:59 p.m. ET.
Notification to late-breaking authors March 21 to 25, 2022

Please carefully read the following guidelines and sample abstract prior to submitting an abstract online

Abstract submission guidelines

  • The abstracts must not have been published Note that selected abstracts will be published as a supplement in Haemophiliajournal, the official Congress book of abstracts.
  • All presenting authors must be paid registrants of the WFH 2022 World Congress by February 7,2022, for regular abstracts and by March 31, 2022, for late-breaking abstracts. After this date, presenting authors who have not paid their registration fees will be excluded from the program, as well as from the Book of Abstracts.
  • The submission of an abstract carries with it the obligation that it will be presented at Congress by the presenting author. Failure to present as scheduled may result in the non-acceptance of future submissions at WFH meetings.
  • Each abstract will be blinded and scored by three reviewers. Abstracts will be accepted based on the following criteria: relevance; interpretation of results; originality and novelty; organization; and clarity.
  • Rule of two: Each author may present a maximum of two abstracts at the Congress. However, authors can make an unlimited number of submissions. Should an author have more than two abstracts accepted, a co-author must be named as the presenting author for the third or more abstracts.
  • Abstracts may not be revised or resubmitted after the deadline date of December 3, 2021
  • Please submit abstract withdrawal requests in writing by February 25, 2022
  • Please submit change of presenting author requests in writing by February 28, 2022. After this date, changes will not appear in the Book of Abstracts.

By submitting an abstract, you consent to the following:

  • If accepted, your abstract may be published in the Haemophilia journal supplement
  • If accepted as an oral presentation, your presentation may be posted on the WFH website, on-site and post-Congress
  • If accepted as a poster presentation, you will display your poster at the Congress
  • Abstracts should be clear, concise, and written and presented in English. Abstracts will be published as submitted. Presenters are requested to carefully proofread their abstract. The Congress Program Committee reserves the right to reject abstracts that are deemed to be poorly written or to request an immediate revision of the text to improve its readability.
  • Abstracts should not exceed 350 words. When calculating your word count, please note that every table or graph in your abstract counts as 50 words each.
  • Images are NOT permitted
  • Be sure to select the appropriate topic category when submitting your abstract to ensure proper consideration. The Program Committee reserves the right to move abstracts to other subjects as they see fit, as well as to add and remove categories as required.
  • Select a preferred presentation type (oral or poster). The Congress Program Committee will determine whether the abstract will be accepted as a free paper, moderated poster, or a poster, with consideration given to the author’s preference, available time, and fit in the Congress program.
  • Your abstract must include the following sections:
    • Introduction and objective
    • Materials and methods
    • Results
    • Conclusions
  • Do NOT include references, credits, or grant support in your abstract
  • Authors and affiliations are to be submitted using the on-line form only. Only one presenting author is permitted per submission.
  • If an author’s name appears on more than one abstract, it must be written in the same way on each abstract to ensure proper indexing
  • Abstracts that describe single clinical cases or lack quantitative data will NOT be accepted. Authors are not to split data to create several abstracts from one. If “splitting” has been judged to have occurred, the priority scores of related abstracts will be reduced.
  • During the abstract process, you will be asked to enter author information and affiliations. Please list the authors in your preferred citation order. If you are submitting supporting graphs or tables, please do not include the author list in the Word document, as we operate by blind review.
  • Use a short, specific title. The title should be entered in sentence case. Do not use a period at the end of the title.
  • Capitalize the first letter of trade names
  • Do NOT use ALL CAPS in the title or in the body text
  • Use standard abbreviations for units of measure; other abbreviations should be spelled out in full at first mention, followed by the abbreviation in parenthesis (exceptions: RNA, DNA, etc.)
  • Special characters: please use the special character palette if you need to use a special character. If you copy and paste your abstract, please be sure to enter special characters using the palette, even if they seem to appear correctly after pasting. If you do not use the special palette, your special characters will not appear properly in publication. Please be sure to double-check during the proofreading step to ensure all special characters were converted properly.

The notification of abstract acceptance or rejection for early abstract submissions will be sent the week of January 10, 2022.

The notification regarding abstract status—as either a free paper or poster presentation—as well as presentation guidelines will be sent during the week of January 10, 2022.

The notification for late-breaking abstracts will be sent the week of March 21, 2022.

Please note that only the corresponding author will be contacted concerning the abstract, and thus the corresponding author is responsible for informing all co-authors of the status of the abstract.

If an author or immediate family member has had a substantial financial relationship relating to the support of the abstract, this relationship must be disclosed. Such relationships include salaries, ownership, equity positions, stock options, royalties, consulting fees and honoraria for speaking, material support and other financial arrangements. During the abstract submission process, you will be asked to disclose any potential conflicts of interest.

The call for late-breaking abstracts opens February 2, 2022. The submission deadline is March 2, 2022, at 11:59 p.m. ET. The status of the peer review will be announced the week of March 21, 2022. The submitter will be notified by email. In case of any abstract related queries please contact [email protected].